Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Packer

Showing results (651-660 of 706) with videos related to

Pageof 71
Sort By:
Brain Pathology (Zurich, Switzerland)|March 5, 2013
Histological predictors of outcome in ependymoma are dependent on anatomic site within the central nervous systemAditya Raghunathan, Khalida Wani, Terri S Armstrong, et al.
Nature Medicine|July 1, 2026
Multi-antigen-targeting T cells in pediatric central nervous system tumors: a phase 1 trialStephanie Gomez, Rachel A DiCioccio, Ashley E Geiger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 19, 2022
Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003Cassie Kline, Payal Jain, Lindsay Kilburn, et al.
The European Respiratory Journal|June 1, 2023
Genome-wide association study of chronic sputum production implicates loci involved in mucus production and infectionRichard J Packer, Nick Shrine, Robert Hall, et al.
American Journal of Medical Genetics. Part A|January 29, 2011
Back to the future: proceedings from the 2010 NF ConferenceSusan M Huson, Maria T Acosta, Allan J Belzberg, et al.
Journal of Medicinal Chemistry|September 12, 2018
Discovery of N-(4-{[5-Fluoro-7-(2-methoxyethoxy)quinazolin-4-yl]amino}phenyl)-2-[4-(propan-2-yl)-1 H-1,2,3-triazol-1-yl]acetamide (AZD3229), a Potent Pan-KIT Mutant Inhibitor for the Treatment of Gastrointestinal Stromal TumorsJason G Kettle, Rana Anjum, Evan Barry, et al.
The Lancet. Oncology|June 6, 2020
Response assessment in paediatric low-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working groupJason Fangusaro, Olaf Witt, Pablo Hernáiz Driever, et al.
International Journal of Cancer|March 13, 2019
A pilot precision medicine trial for children with diffuse intrinsic pontine glioma-PNOC003: A report from the Pacific Pediatric Neuro-Oncology ConsortiumSabine Mueller, Payal Jain, Winnie S Liang, et al.
Annals of Clinical and Translational Neurology|December 5, 2019
Reproducibility of cognitive endpoints in clinical trials: lessons from neurofibromatosis type 1Jonathan M Payne, Stephen J C Hearps, Karin S Walsh, et al.
Neuro-Oncology|June 11, 2016
Pediatric high-grade glioma: biologically and clinically in need of new thinkingChris Jones, Matthias A Karajannis, David T W Jones, et al.
Pageof 71

Showing results (651-660 of 706) with videos related to

Sort By:
Pageof 71
Brain Pathology (Zurich, Switzerland)|March 5, 2013
Histological predictors of outcome in ependymoma are dependent on anatomic site within the central nervous systemAditya Raghunathan, Khalida Wani, Terri S Armstrong, et al.
Nature Medicine|July 1, 2026
Multi-antigen-targeting T cells in pediatric central nervous system tumors: a phase 1 trialStephanie Gomez, Rachel A DiCioccio, Ashley E Geiger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 19, 2022
Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003Cassie Kline, Payal Jain, Lindsay Kilburn, et al.
The European Respiratory Journal|June 1, 2023
Genome-wide association study of chronic sputum production implicates loci involved in mucus production and infectionRichard J Packer, Nick Shrine, Robert Hall, et al.
American Journal of Medical Genetics. Part A|January 29, 2011
Back to the future: proceedings from the 2010 NF ConferenceSusan M Huson, Maria T Acosta, Allan J Belzberg, et al.
Journal of Medicinal Chemistry|September 12, 2018
Discovery of N-(4-{[5-Fluoro-7-(2-methoxyethoxy)quinazolin-4-yl]amino}phenyl)-2-[4-(propan-2-yl)-1 H-1,2,3-triazol-1-yl]acetamide (AZD3229), a Potent Pan-KIT Mutant Inhibitor for the Treatment of Gastrointestinal Stromal TumorsJason G Kettle, Rana Anjum, Evan Barry, et al.
The Lancet. Oncology|June 6, 2020
Response assessment in paediatric low-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working groupJason Fangusaro, Olaf Witt, Pablo Hernáiz Driever, et al.
International Journal of Cancer|March 13, 2019
A pilot precision medicine trial for children with diffuse intrinsic pontine glioma-PNOC003: A report from the Pacific Pediatric Neuro-Oncology ConsortiumSabine Mueller, Payal Jain, Winnie S Liang, et al.
Annals of Clinical and Translational Neurology|December 5, 2019
Reproducibility of cognitive endpoints in clinical trials: lessons from neurofibromatosis type 1Jonathan M Payne, Stephen J C Hearps, Karin S Walsh, et al.
Neuro-Oncology|June 11, 2016
Pediatric high-grade glioma: biologically and clinically in need of new thinkingChris Jones, Matthias A Karajannis, David T W Jones, et al.
Pageof 71